Unknown NA INTERVENTIONAL 1-arm NCT03923777

Active Surveillance in Early Lung Cancer (ACTION-Lung)

Pilot Study Involving Active Surveillance With CT Imaging and Liquid BiOpsies iN Stage IA Lung Cancer (ACTION-Lung)

Sponsor: University of Vermont Medical Center

Conditions Lung Carcinoid Tumor Stage IA Non-small Cell Lung Cancer

Updated 6 times since 2019 Last updated: Jul 14, 2020 Started: Jul 31, 2018 Primary completion: Dec 31, 2020 Completion: Jul 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03923777, this NA trial focuses on Lung Carcinoid Tumor and Stage IA Non-small Cell Lung Cancer and remains ongoing. Sponsored by University of Vermont Medical Center, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Sep 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Sep 2022 [monthly]

Enrolling By Invitation NA
Aug 2020 — Jan 2021 [monthly]

Enrolling By Invitation NA

▶ Show 1 earlier version

May 2019 — Aug 2020 [monthly]

Enrolling By Invitation NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Vermont Medical Center

Data source: University of Vermont Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Burlington, United States